Hydroxyethylstarches and renal failure: To keep the reason is a necessity

Annales Francaises d'Anesthesie et de Reanimation

Volumn 32, Issue 9, 2013, Pages 535-538

  Godet, G ^a   Girard, C ^b   Guidet, B ^c   Ichai, C ^d   Lehot, J J ^e   Leone, M ^f   Martin, C ^f   Muller, L ^g   Orliaguet, G ^h   Payen, J F ⁱ   Sztark, F ^j  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DU BOCAGE   (France)

^c HÔpital Saint Antoine   (France)

^d University Hospital of Nice University of Nice Sophia Antipolis   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f HÔPITAL NORD   (France)

^g DEPARTMENT OF NEUROLOGY   (France)

^h HÔpital Necker Enfants Malades   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j HÔPITAL PELLEGRIN   (France)

more..

Author keywords

Hydroxyethylstarches; Renal failure

Indexed keywords

HETASTARCH; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE; COLLOID;

EDITORIAL; KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; COLLOID; FLUID THERAPY; HUMAN; HYDROXYÉTHYLAMIDONS; HYDROXYETHYLSTARCHES; INTENSIVE CARE; REINS; CHEMICALLY INDUCED; RENAL INSUFFICIENCY;

HYDROXYÉTHYLAMIDONS; HYDROXYETHYLSTARCHES; REINS; RENAL FAILURE;

COLLOIDS; CRITICAL CARE; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; PLASMA SUBSTITUTES; RENAL INSUFFICIENCY;

EID: 84884141774     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2013.07.792     Document Type: Editorial

References (19)

1. Brunkhorst F.M., Oppert M. Nephrotoxicity of hydroxyethyl starch solution. Br J Anaesth 2008, 100:856.
2. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
3. Brochard L., Schortgen F., Brun-Buisson C. Pour un moratoire sur l'utilisation des hydroxyéthylamidons. Reanimation 2008, 17:588-591.
4. Cittanova M.L., Leblanc I., Legendre C., Mouquet C., Riou B., Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996, 348:1620-1622.
5. Cittanova M.L., Mavré J., Riou B., Coriat P. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors. Intensive Care Med 2001, 1830.
6. Schortgen F., Girou E., Deye N., Brochard L., CRYCO Study Group The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008, 2157-2168.
7. Myburgh J.A., Finfer S., Bellomo R., Billot L., Cass A., Gattas D., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012, 367:1901-1911.
8. Crystalloid versus Hydroxyethyl Starch Trial (CHEST) Management Committee The crystalloid versus hydroxyethyl starch trial: protocol for a multicentre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Med 2011, 37:816-823.
9. Perner A., Haase N., Guttormsen A.B., Tenhunen J., Klemenzson G., Åneman A., et al. Hydroxyethyl starch 130/0.42versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134.
10. Dart A.B., Mutter T.C., Ruth C.A., Taback S.P. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010, (1):CD007594.
11. CRISTAL Efficacy and safety of colloids versus crystalloids for fluid resuscitation in critically ill patients-NCT00318942 2013, SRLF, Paris, [Bruxelles; ESICM].
12. Muller L., Jaber S., Molinari N., Favier L., Larché J., Motte G., et al. Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock. Crit Care 2012, 16:R34.
13. Martin C., Jacob M., Vicaut E., Guidet B., Van Aken H., Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4on renal function in surgical patients. Anesthesiology 2013, 118:387-394.
14. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.
15. Van Der Linden P., James M., Mythen M., Weiskopf R.B. Safety of modern starches used during surgery. Anesth Analg 2013, 116:35-48.
16. ®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 2008, 12:986-994.
17. Payen J.F., Vigue B., Audibert G., Bruder N. Should we ban the use of colloids in patients with head injury?. Intensive Care Med 2012, 38:1561-1562.
18. Guidet B., Martinet O., Boulain T., Philippart F., Poussel J.F., Maizel J., et al. Assessment of haemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0·4versus 0·9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012, 16:R94.
19. Guidet B. Hydroxyethyl starch or saline in intensive care. Correspondance. N Engl J Med 2013, 368:774.